Product overview

Product overview

The content of this evidence summary was up to date in March 2022. See summaries of product characteristics (SPCs), British national formulary (BNF) or the Medicines and Healthcare products Regulatory Agency (MHRA) or NICE websites for up-to-date information.

Eravacycline (Xerava, PAION Deutschland GmbH) is a tetracycline antibiotic given intravenously. It has a marketing authorisation for treating complicated intra-abdominal infections in adults.